NCT07646262 Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis
| NCT ID | NCT07646262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hasan Kalyoncu University |
| Condition | Rheumatoid Arthritis (RA |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2025-10-29 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2025-10-29 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effects of different dietary interventions, including gluten-free, Mediterranean, and control diets, on disease activity, quality of life, and dietary inflammatory index in patients with rheumatoid arthritis. Participants will be followed for 12 weeks, and changes in clinical and nutritional outcomes will be assessed.
Eligibility Criteria
Inclusion Criteria: Diagnosis of rheumatoid arthritis according to ACR/EULAR criteria Age between 19-65 years Stable medication regimen for at least 3 months prior to enrollment Willingness to comply with dietary interventions and study procedures Ability to provide informed consent Exclusion Criteria: Pregnancy or lactation Presence of other autoimmune or inflammatory diseases (e.g., SLE, IBD) Severe comorbidities (e.g., advanced cardiovascular, renal, or hepatic disease) Use of special diets (e.g., gluten-free diet) in the last 3 months Recent change in biologic or corticosteroid therapy (\<3 months) Food allergies or intolerances affecting dietary intervention adherence Inability to comply with dietary protocol or follow-up visits
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07646262 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 65 Years, studying Rheumatoid Arthritis (RA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07646262 currently recruiting?
Yes, NCT07646262 is actively recruiting participants. Contact the research team at nilufergursell@gmail.com for enrollment information.
Where is the NCT07646262 trial being conducted?
This trial is being conducted at Gaziantep, Turkey (Türkiye).
Who is sponsoring the NCT07646262 clinical trial?
NCT07646262 is sponsored by Hasan Kalyoncu University. The trial plans to enroll 66 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.